HPV vax appears to stop skin cancer in intriguing trial
Human papilloma virus (HPV) vaccination could play a role in preventing squamous and basal cell carcinomas, findings in high-risk patients suggest.
Intriguing findings in JAMA Dermatology are the first-ever report of quadrivalent HPV vaccination used to prevent skin cancers.
The researchers detail the cases of two patients — a man in his 70s and a woman in her 80s — with a history of multiple keratinocyte carcinomas.
Each patient received three doses of the qHPV vaccine over a six-month period and underwent full body examinations every